Exagen (XGN) Deferred Taxes (2020 - 2021)
Exagen's (XGN) quarterly Deferred Taxes came in at $148000.0 in Q4 2021, up 1245.45% YoY from $11000.0 in Q4 2020, and up 1245.45% on a QoQ basis from $11000.0 in Q4 2020.
Exagen (XGN) Deferred Taxes (2020 - 2021) Analysis & Trends
Exagen (XGN) has 2 years of Deferred Taxes data on file, last reported at $148000.0 in Q4 2021.
- Quarterly Deferred Taxes rose 1245.45% year-over-year to $148000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $148000.0 (up 239.62% YoY) and the FY2022 annual result came in at -$306000.0, down 306.76% from the prior year.
- Deferred Taxes climbed to $148000.0 in Q4 2021, from $11000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $148000.0 in Q4 2021 to a low of -$117000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -208.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 6.54 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 32.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -36.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 1.82 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -2.00 Mn |
| 10 | Exagen | 158.28 Mn | 133.68 Mn | 12.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 148,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Mar 31, 2020 | -117,000.00 |